Clinical Trial Update: A Clinical Study to Assess the Effect of Food and Gender on the Pharmacokinetics of SRT2104 Administered as an Oral Suspension or Capsule Formulation to Normal Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study in healthy volunteers to assess how food and gender affect the pharmacokinetics of SRT2104 given as an oral suspension or capsul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SRT2104 (SRT2104)

Snippet

Sponsor: Sirtris, a GSK Company | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED